Neuron-Specific Enolase (NSE) Predicts Long-Term Mortality in Adult Patients after Cardiac Arrest: Results from a Prospective Trial.
Jonas MüllerBenjamin BissmannChristoph BeckerKatharina BeckNina LoretzSebastian GrossSimon A AmacherChantal BohrenHans ParggerKai TisljarRaoul SutterStephan C MarschSabina HunzikerPublished in: Medicines (Basel, Switzerland) (2021)
NSE measured three days after cardiac arrest is associated with long-term mortality and neurological outcome and may provide prognostic information that improves clinical decision making. Particularly in the subgroup of younger patients (<54 years), NSE showed excellent negative predictive value.
Keyphrases
- cardiac arrest
- cardiopulmonary resuscitation
- end stage renal disease
- decision making
- cardiovascular events
- chronic kidney disease
- ejection fraction
- newly diagnosed
- phase iii
- peritoneal dialysis
- risk factors
- prognostic factors
- study protocol
- clinical trial
- healthcare
- type diabetes
- cardiovascular disease
- patient reported outcomes
- health information